Sitagliptin

The Role of Phosphodiesterase Inhibitors in Incretin Secretion

Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes

Disease-modifying Efficacy of Sitagliptin Therapy in Early-stage Parkinson's Disease

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.

A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

Sitagliptin With Pembro in RCC and Melanoma

Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer

Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment

Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.

Emulation of the EMPEROR-Reduced Trial Using Healthcare Claims Data

INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)

Emulation of the EMPEROR-Preserved Trial Using Healthcare Claims Data

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

Anti-Diabetic Medications to Fight PD and LBD

Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk

A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1